Nano-flow liquid chromatography tandem mass spectrometry (nano-flow LC-MS/MS) is the mainstay in proteome research because of its excellent sensitivity but often comes at the expense of robustness. Here we show that micro-flow LC-MS/MS using a 1 × 150 mm column shows excellent reproducibility of chromatographic retention time (2000 samples of human cell lines, tissues and body fluids. Deep proteome analysis identifies >9000 proteins and >120,000 peptides in 16 h and sample multiplexing using tandem mass tags increases throughput to 11 proteomes in 16 h. The system identifies >30,000 phosphopeptides in 12 h and protein-protein or protein-drug interaction experiments can be analyzed in 20 min per sample. We show that the same column can be us...
Capillary- and micro-flow liquid chromatography–tandem mass spectrometry (capLC–MS/MS and μLC–MS/MS)...
The use of a proper sample processing methodology for maximum proteome coverage and high-quality qua...
Background: Variability of plasma sample collection and of proteomics technology platforms has been ...
To further integrate mass spectrometry (MS)-based proteomics into biomedical research and especially...
Quantitative proteomics is key for basic research, but needs improvements to satisfy an increasing d...
Introduction : When aiming for comprehensive proteome analysis with deep coverage, relatively long n...
Recent advances in mass spectrometry (MS)-based proteomics now allow very deep coverage of cellular ...
The deployment of proteomic analysis in clinical studies represents a significant opportunity to det...
AbstractA variable flow “peak trapping” liquid chromatography (LC) interface has been developed for ...
Due to its sensitivity and productivity, bottom-up proteomics based on liquid chromatography–mass sp...
One of the greatest challenges for mass spectrometry (MS)-based proteomics is the limited ability to...
The field of proteomics has evolved hand-in-hand with technological advances in LC-MS/MS systems, no...
Although current LC-MS technology permits scientists to efficiently screen clinical samples in trans...
Recent improvements in the speed and sensitivity of liquid chromatography-mass spectrometry systems ...
Single-cell technologies are revolutionizing biology but are today mainly limited to imaging and dee...
Capillary- and micro-flow liquid chromatography–tandem mass spectrometry (capLC–MS/MS and μLC–MS/MS)...
The use of a proper sample processing methodology for maximum proteome coverage and high-quality qua...
Background: Variability of plasma sample collection and of proteomics technology platforms has been ...
To further integrate mass spectrometry (MS)-based proteomics into biomedical research and especially...
Quantitative proteomics is key for basic research, but needs improvements to satisfy an increasing d...
Introduction : When aiming for comprehensive proteome analysis with deep coverage, relatively long n...
Recent advances in mass spectrometry (MS)-based proteomics now allow very deep coverage of cellular ...
The deployment of proteomic analysis in clinical studies represents a significant opportunity to det...
AbstractA variable flow “peak trapping” liquid chromatography (LC) interface has been developed for ...
Due to its sensitivity and productivity, bottom-up proteomics based on liquid chromatography–mass sp...
One of the greatest challenges for mass spectrometry (MS)-based proteomics is the limited ability to...
The field of proteomics has evolved hand-in-hand with technological advances in LC-MS/MS systems, no...
Although current LC-MS technology permits scientists to efficiently screen clinical samples in trans...
Recent improvements in the speed and sensitivity of liquid chromatography-mass spectrometry systems ...
Single-cell technologies are revolutionizing biology but are today mainly limited to imaging and dee...
Capillary- and micro-flow liquid chromatography–tandem mass spectrometry (capLC–MS/MS and μLC–MS/MS)...
The use of a proper sample processing methodology for maximum proteome coverage and high-quality qua...
Background: Variability of plasma sample collection and of proteomics technology platforms has been ...